AR-V7 biomarker testing for primary prostate cancer: The ongoing challenge of analytical validation and clinical qualification

Cancer Treat Res Commun. 2021:28:100218. doi: 10.1016/j.ctarc.2020.100218. Epub 2020 Oct 9.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Biomarkers
  • Humans
  • Longitudinal Studies
  • Male
  • Phenylthiohydantoin
  • Prostatic Neoplasms, Castration-Resistant*

Substances

  • Biomarkers
  • Phenylthiohydantoin